Wagener MM - Search Results

1

Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group. Sun HY, et al. Among authors: wagener mm. Clin Infect Dis. 2010 Nov 1;51(9):1062-9. doi: 10.1086/656584. Clin Infect Dis. 2010. PMID: 20879857

2

Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes.

Muder RR, Brennen C, Wagener MM, Goetz AM. Muder RR, et al. Among authors: wagener mm. Clin Infect Dis. 1992 Mar;14(3):647-54. doi: 10.1093/clinids/14.3.647. Clin Infect Dis. 1992. PMID: 1562655

3

Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants.

Singh N, Gayowski T, Wagener M, Yu VL. Singh N, et al. Transplantation. 1994 Oct 15;58(7):774-8. Transplantation. 1994. PMID: 7524204

4

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.

Singh N, Gayowski T, Yu VL, Wagener MM. Singh N, et al. Among authors: wagener mm. Ann Intern Med. 1995 Apr 15;122(8):595-8. doi: 10.7326/0003-4819-122-8-199504150-00007. Ann Intern Med. 1995. PMID: 7887554 Clinical Trial.

5

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial.

Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. Singh N, et al. Among authors: wagener mm. Ann Intern Med. 1994 Mar 1;120(5):375-81. doi: 10.7326/0003-4819-120-5-199403010-00004. Ann Intern Med. 1994. PMID: 8304654 Clinical Trial.

6

Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease.

Singh N, Yu VL, Mieles LA, Wagener MM. Singh N, et al. Among authors: wagener mm. Am J Med. 1993 Mar;94(3):251-6. doi: 10.1016/0002-9343(93)90056-u. Am J Med. 1993. PMID: 8452148

7

Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies.

Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Singh N, et al. Transplantation. 1996 Feb 15;61(3):396-401. doi: 10.1097/00007890-199602150-00013. Transplantation. 1996. PMID: 8610349

8

Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis.

Singh N, Gayowski T, Wagener MM, Marino IR. Singh N, et al. Among authors: wagener mm. Transplantation. 1996 Feb 15;61(3):402-6. doi: 10.1097/00007890-199602150-00014. Transplantation. 1996. PMID: 8610350

9

Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation.

Singh N, Gayowski T, Ndimbie OK, Nedjar S, Wagener MM, Yu VL. Singh N, et al. Among authors: wagener mm. Surgery. 1996 Apr;119(4):452-6. doi: 10.1016/s0039-6060(96)80147-4. Surgery. 1996. PMID: 8644012

10

Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy.

Singh N, Gayowski T, Wannstedt CF, Marino IR, Wagener MM. Singh N, et al. Among authors: wagener mm. Clin Transplant. 1996 Aug;10(4):348-51. Clin Transplant. 1996. PMID: 8884107 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page